NRXP NRX Pharmaceuticals
- 3.9000
- +0.0400+1.04%
- 3.8800
- -0.0200-0.51%
NRX Pharmaceuticals News
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million. SINTX Techs (NASDAQ:SINT) sha
NRX Pharmaceuticals Eyes $30M Refinancing and Funding Deal
Earnings Call Summary | NRX Pharmaceuticals(NRXP.US) Q1 2024 Earnings Conference
The following is a summary of the NRx Pharmaceuticals, Inc. (NRXP) Q1 2024 Earnings Call Transcript:Financial Performance:NRx Pharmaceuticals reported a Q1 2024 net loss of $6.5 million, a reduction o
NRX Pharmaceuticals Q1 EPS $(0.74) Misses $(0.37) Estimate
NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.37) by 100 percent. This is a 53.75 percent increase over losses of
10-Q: Quarterly report
NRX Pharmaceuticals 1Q Loss $6.5M >NRXP
NRX Pharmaceuticals 1Q Loss $6.5M >NRXP
Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update PR Newswire RADNOR, Pa., May 14, 2024 2024 Catalysts: Positive Clinical Data, Two Planned
NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it...
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024
RADNOR, Pa., May 7, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will rele
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) stoc
NRx Pharmaceuticals Shares Are Trading Higher After the Company Announced a Statistically Significant Safety Advantage of NRX-101 Compared to the Standard of Care Comparator in Its Recently Completed Clinical Trial in Patients With Suicidal Bipolar...
NRx Pharmaceuticals Shares Are Trading Higher After the Company Announced a Statistically Significant Safety Advantage of NRX-101 Compared to the Standard of Care Comparator in Its Recently Completed
NRx Pharmaceuticals Climbs on Positive Results From Its Bipolar Depression Treatment Trial
NRx Pharmaceuticals (NASDAQ:NRXP) shares rise about 5% premarket after the company announced a statistically significant safety advantage of NRX-101 compared to the standard of care comparator in its recently completed clinical trial in patients with suicidal bipolar depression.
Canopy Growth, Caredx, CytomX Therapeutics Among Healthcare Movers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) shares moved upwards by 69.1% to $0.16 during Wednesday's pre-market session. The company's market cap stands at $1.8 million. NanoVibronix (NASDAQ:NAOV) shares moved upwar
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersPredictive Oncology (NASDAQ:POAI) shares rose 36.4% to $1.95 during Tuesday's after-market session. The company's market cap stands at $7.9 million. Brainstorm Cell (NASDAQ:BCLI) shares moved u
BKKT, CETX and SWVL Among Mid-day Movers
Cyclacel CYCC Private Placement; NRx Pharmaceuticals NRXP Phase 2b/3 Failure
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of H&E Equipment Services, Inc. (NASDAQ:HEES) fell sharply during Tuesday's session following mixed first-quarter results.H&E Equipment posted GAAP earnings of 71 cents per share, versus market
Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study
NRx Pharmaceuticals Inc (NASDAQ:NRXP) shares are down 23.1% at $2.73 at last check Tuesday.The stock plummet occurred on the heels of the company's latest study: the Phase 2b/3 trial of NRX-101 vs. Lu
Analysis
Price Target
No Data
